CH623337A5 - - Google Patents
Download PDFInfo
- Publication number
- CH623337A5 CH623337A5 CH1195176A CH1195176A CH623337A5 CH 623337 A5 CH623337 A5 CH 623337A5 CH 1195176 A CH1195176 A CH 1195176A CH 1195176 A CH1195176 A CH 1195176A CH 623337 A5 CH623337 A5 CH 623337A5
- Authority
- CH
- Switzerland
- Prior art keywords
- lactone
- pregn
- oxo
- carboxylic acid
- dihydroxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/001—Lactones
- C07J21/003—Lactones at position 17
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/911—Microorganisms using fungi
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/615,412 US3972871A (en) | 1975-09-22 | 1975-09-22 | 6β,17-Dihydroxy-7α-(lower alkoxy)carbonyl-3-oxo-17α-pregn-4-ene-21-carboxylic acid γ-lactones and congeners |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH623337A5 true CH623337A5 (fi) | 1981-05-29 |
Family
ID=24465262
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1195176A CH623337A5 (fi) | 1975-09-22 | 1976-09-21 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US3972871A (fi) |
| JP (1) | JPS5248657A (fi) |
| AT (1) | AT352305B (fi) |
| AU (1) | AU499083B2 (fi) |
| BE (1) | BE846437A (fi) |
| CA (1) | CA1071620A (fi) |
| CH (1) | CH623337A5 (fi) |
| DE (1) | DE2642400A1 (fi) |
| DK (1) | DK138995B (fi) |
| ES (1) | ES451701A1 (fi) |
| FI (1) | FI55670C (fi) |
| FR (1) | FR2324309A1 (fi) |
| GB (1) | GB1520948A (fi) |
| GR (1) | GR61185B (fi) |
| IE (1) | IE44350B1 (fi) |
| IL (1) | IL50524A (fi) |
| NL (1) | NL7610477A (fi) |
| NO (1) | NO143910C (fi) |
| NZ (1) | NZ182127A (fi) |
| PT (1) | PT65616B (fi) |
| SE (1) | SE418295B (fi) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3972871A (en) * | 1975-09-22 | 1976-08-03 | G. D. Searle & Co. | 6β,17-Dihydroxy-7α-(lower alkoxy)carbonyl-3-oxo-17α-pregn-4-ene-21-carboxylic acid γ-lactones and congeners |
| US4069219A (en) * | 1976-12-27 | 1978-01-17 | G. D. Searle & Co. | 7ξ-(Alkoxycarbonyl)-6ξ-alkyl/halo-17-hydroxy-3-oxo-17α-pregn-4-ene-21-carboxylic acid γ-lactones and corresponding 21-carboxylic acids, their salts, and esters |
| JPS6063577U (ja) * | 1983-10-07 | 1985-05-04 | 東レ株式会社 | 糸条のインタ−レ−ス装置 |
| DK0973791T3 (da) * | 1995-12-11 | 2007-09-17 | Searle Llc | Fremgangsmåde til fremstilling af en epoxyforbindelse |
| US6887991B1 (en) * | 1996-12-11 | 2005-05-03 | G. D. Searle & Company | Processes for preparation of 9, 11-epoxy steroids and intermediates useful therein |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2237143A1 (de) * | 1972-07-28 | 1974-02-14 | Hoechst Ag | Verfahren zur herstellung von beta(3-keto-7alpha-acetylthio-17beta-hydroxy4-androsten-17alpha-yl)-propionsaeuregamma-lacton und dessen 1-dehydro-derivat |
| GB1368006A (en) * | 1972-08-24 | 1974-09-25 | Searle & Co | 4alpha,7alpha-carbonyl-5-cyano-17-hzydroxy-3-oxo-5beta,17alpha- pregnane-21-carboxylic acid ypsilon-lactone |
| US3972871A (en) * | 1975-09-22 | 1976-08-03 | G. D. Searle & Co. | 6β,17-Dihydroxy-7α-(lower alkoxy)carbonyl-3-oxo-17α-pregn-4-ene-21-carboxylic acid γ-lactones and congeners |
-
1975
- 1975-09-22 US US05/615,412 patent/US3972871A/en not_active Expired - Lifetime
-
1976
- 1976-09-21 SE SE7610449A patent/SE418295B/xx unknown
- 1976-09-21 IE IE2083/76A patent/IE44350B1/en unknown
- 1976-09-21 NL NL7610477A patent/NL7610477A/xx not_active Application Discontinuation
- 1976-09-21 CA CA261,650A patent/CA1071620A/en not_active Expired
- 1976-09-21 FI FI762690A patent/FI55670C/fi not_active IP Right Cessation
- 1976-09-21 NO NO763231A patent/NO143910C/no unknown
- 1976-09-21 DE DE19762642400 patent/DE2642400A1/de not_active Withdrawn
- 1976-09-21 JP JP51113555A patent/JPS5248657A/ja active Pending
- 1976-09-21 NZ NZ182127A patent/NZ182127A/xx unknown
- 1976-09-21 FR FR7628325A patent/FR2324309A1/fr active Granted
- 1976-09-21 AU AU17962/76A patent/AU499083B2/en not_active Expired
- 1976-09-21 DK DK425176AA patent/DK138995B/da unknown
- 1976-09-21 GR GR51740A patent/GR61185B/el unknown
- 1976-09-21 ES ES451701A patent/ES451701A1/es not_active Expired
- 1976-09-21 IL IL50524A patent/IL50524A/xx unknown
- 1976-09-21 AT AT698476A patent/AT352305B/de not_active IP Right Cessation
- 1976-09-21 PT PT65616A patent/PT65616B/pt unknown
- 1976-09-21 CH CH1195176A patent/CH623337A5/de not_active IP Right Cessation
- 1976-09-22 BE BE170815A patent/BE846437A/xx unknown
- 1976-09-22 GB GB39393/76A patent/GB1520948A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| PT65616B (en) | 1978-04-05 |
| DK138995B (da) | 1978-11-27 |
| BE846437A (fr) | 1977-03-22 |
| FI55670C (fi) | 1979-09-10 |
| IL50524A0 (en) | 1976-11-30 |
| GB1520948A (en) | 1978-08-09 |
| SE418295B (sv) | 1981-05-18 |
| NL7610477A (nl) | 1977-03-24 |
| DK425176A (fi) | 1977-03-23 |
| AT352305B (de) | 1979-09-10 |
| IE44350B1 (en) | 1981-11-04 |
| IE44350L (en) | 1977-03-22 |
| US3972871A (en) | 1976-08-03 |
| NO143910C (no) | 1981-06-03 |
| NO143910B (no) | 1981-01-26 |
| FR2324309B1 (fi) | 1979-03-02 |
| IL50524A (en) | 1979-12-30 |
| DE2642400A1 (de) | 1977-03-24 |
| DK138995C (fi) | 1979-05-14 |
| ES451701A1 (es) | 1978-01-01 |
| FR2324309A1 (fr) | 1977-04-15 |
| AU499083B2 (en) | 1979-04-05 |
| SE7610449L (sv) | 1977-03-23 |
| GR61185B (en) | 1978-10-05 |
| JPS5248657A (en) | 1977-04-18 |
| CA1071620A (en) | 1980-02-12 |
| AU1796276A (en) | 1978-04-06 |
| ATA698476A (de) | 1979-02-15 |
| FI762690A (fi) | 1977-03-23 |
| PT65616A (en) | 1976-10-01 |
| FI55670B (fi) | 1979-05-31 |
| NO763231L (no) | 1977-03-23 |
| NZ182127A (en) | 1978-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2513212C2 (de) | Methyl-7-[3-hydroxy-2-(4-hydroxy-4-methyl-trans-1-octenyl)-5-oxocyclopentan]-1-heptanoat, Verfahren zu dessen Herstellung und diese Verbindung enthaltende Präparate | |
| DE2760005C2 (de) | Optisch aktive Norpinene und Verfahren zu ihrer Herstellung | |
| DE2323215B2 (de) | Pregna-1,4-dien-11-ol-3,20-dione, verfahren zu deren herstellung und sie enthaltende arzneimittel | |
| DE2710242A1 (de) | 5-eckige klammer auf 1,1-diphenyl- 3-(5- oder 6-hydroxy-2-azabicyclo eckige klammer auf 2,2,2 eckige klammer zu oct-2-yl)propyl eckige klammer zu -2- alkyl-1,3,4-oxadiazole und verwandte verbindungen | |
| DE2651773C3 (de) | 14-Acyloxy-daunorubicine, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen | |
| CH637408A5 (de) | Verfahren zur herstellung von 6-fluor-17-alpha-pregnanderivaten. | |
| CH623337A5 (fi) | ||
| DD210027B3 (de) | Verfahren zur herstellung von carbacyclinderivaten | |
| CH509297A (de) | Verfahren zur Herstellung von in 17-Stellung durch ungesättigte Kohlenwasserstoffreste substituierten 11,13B-Dialkylgon-4-en-3,17B-diolen | |
| DE3028643C2 (fi) | ||
| DE2700434A1 (de) | Prostaglandin-derivate, verfahren zu ihrer herstellung und arzneipraeparate | |
| EP0313935B1 (de) | Enolether von 6-Chlor-4-hydroxy-2-methyl-N-(2-pyridyl)-2H-thieno(2,3-e)-1,2-thiazin-3-carbonsäureamid-1,1-dioxid, ein Verfahren zu ihrer Herstellung sowie ihre Verwendung | |
| DE2167181B1 (de) | Methyl-N-acetyl-6,7-aziridino-6-desamino-7-desoxy-2,3,4-tri-0-acetyl-alpha-thiolincosaminid und Verfahren zu dessen Herstellung | |
| EP0013955B1 (de) | Neue Analoga von Prostacyclin, deren Zwischenprodukte, Verfahren zu ihrer Herstellung sowie sie enthaltende Arzneimittel | |
| DE2443746A1 (de) | 4',5-dihydro-7alpha-alkoxycarbonylspiro eckige klammer auf androst-4-en17,2'(3'h)-furan eckige klammer zu -3-one und entsprechende delta hoch 1,4-verbindungen | |
| DE1695500C3 (de) | Verfahren zum Herstellen von 1-Methyl-S-nitrobnidazolverbindungen | |
| DE2361391A1 (de) | 2-methyl-5-nitro-1-(2-phenylthioaethyl) imidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische mittel | |
| CH639950A5 (de) | Verfahren zur herstellung von neuen 13-thiaprostansaeurederivaten. | |
| DE2709347A1 (de) | Erythro-15,16-dioxyprostensaeuren und -ester sowie verfahren zu ihrer herstellung | |
| DE2319873C2 (de) | 16-O-Alkylderivate von Gitoxigenin-digitoxosiden, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel | |
| DE2553065A1 (de) | (6s)-17'-hydroxy-3'-oxospiro- eckige klammer auf oxiran-2,6'-(17alpha)- pregn-(4)-en eckige klammer zu -21'-carbonsaeure-gamma-lacton und dessen delta hoch 1,4 -analoges, verfahren zur herstellung dieser verbindungen und pharmazeutische zubereitung, die diese verbindungen enthaelt | |
| DE2650366A1 (de) | Antitumor - praeparat | |
| DE2435331C2 (de) | Analoga von Prostansäuren und Verfahren zu ihrer Herstellung sowie diese Analoga von Prostansäuren enthaltende Arzneimittel | |
| DE3327811A1 (de) | Neue valepotriathydrinhaltige arzneimittel | |
| DE1468681C3 (de) | 17beta-Tetrahydropyranyloxy verbindungen der Androstanreihe sowie Verfahren zu ihrer Herstellung und Heilmittel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |